Literature DB >> 17008983

Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.

Patrick K Y Goon, Gregory Y H Lip.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008983     DOI: 10.1007/s11239-006-8983-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  7 in total

1.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors:  Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

Review 2.  Endothelial progenitor cells: characterization and role in vascular biology.

Authors:  Carmen Urbich; Stefanie Dimmeler
Journal:  Circ Res       Date:  2004-08-20       Impact factor: 17.367

3.  Preoteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

4.  Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Claudio T Mesquita; Maria I D Rossi; Antonio C Carvalho; Helio S Dutra; Hans J F Dohmann; Guilherme V Silva; Luciano Belém; Ricardo Vivacqua; Fernando O D Rangel; Roberto Esporcatte; Yong J Geng; William K Vaughn; Joao A R Assad; Evandro T Mesquita; James T Willerson
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

5.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

6.  Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.

Authors:  Kaeng W Lee; Gregory Y H Lip; Muzahir Tayebjee; William Foster; Andrew D Blann
Journal:  Blood       Date:  2004-09-16       Impact factor: 22.113

7.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.